News MedImmune central to AstraZeneca-Amgen antibody deal – Washington Business Journal Pharmaceutical giants AstraZeneca PLC and Amgen Inc. just announced a deal to co-develop and co-commercialize…Super UserApril 5, 2012
News Biotech Can’t Sidestep Cost-Effectiveness Anymore | Xconomy Back in the old days of biotech, the business was pretty straightforward. You’d craft your…Super UserApril 5, 2012
News What venture capitalists look for in personalized medicine investments Companies like Starbucks (NASDAQ:SBUX), Amazon.com (NASDAQ:AMZN) and Apple (NASDAQ:AAPL) aren’t healthcare companies, but one venture…Super UserApril 5, 2012
News Gene mapping isn’t a crystal ball for future health… yet – NY Daily News Gene scans for everyone? Not so fast. New research suggests that for the average person,…Super UserApril 3, 2012
News Emergent’s Fuad El-Hibri, an entrepreneur at heart Fuad El-Hibri has started a financial consulting business. He’s started telecommunications businesses. But his most…Super UserApril 3, 2012
News UNH Center for Venture Research: U.S. Angel Investor Market on Solid Path of Recovery in 2011 Following a considerable contraction in investment dollars in 2008 and 2009, the U.S. angel investor…Super UserApril 3, 2012
News AstraZeneca links up with Amgen for treatments development Shares in AstraZeneca ticked up after the Anglo-Swedish drugs giant announced a tie-up with biotechnology…Super UserApril 3, 2012
News Big Pharma Cozies Up to Biotech – DailyFinance Pharmaceuticals have figured that out that if they can't be as innovative or nimble as…Super UserMarch 31, 2012
News Johns Hopkins top R&D spender for 32nd straight year in 2010 – Baltimore Business Journal Surprise, surprise — Johns Hopkins University spent more money on medical, science and engineering…Super UserMarch 30, 2012
News Video Interview: America’s CTO Catalyzes Health Entrepreneurship through Open Data No matter how privatized healthcare is in America, at the end of the day it…Super UserMarch 30, 2012